金浦钛业股份有限公司董事会 关于独立董事独立性自查情况的专项报告 经核查，独立董事单文峰、孙洋的任职经历以及签署的相关自查 文件，上述人员未在公司担任除独立董事以外的任何职务，也未在公 司主要股东公司担任任何职务，与公司以及主要股东之间不存在利害 关系或其他可能妨碍其进行独立客观判断的关系，不存在影响独立董 事独立性的情况，符合《上市公司独立董事管理办法》《深圳证券交 易所上市公司自律监管指引第 1 号——主板上市公司规范运作》中对 独立董事独立性的相关要求。 金浦钛业股份有限公司 董事会 二〇二五年四月二十八日 根据《上市公司独立董事管理办法》《深圳证券交易所股票上市 规则》《深圳证券交易所上市公司自律监管指引第 1 号——主板上市 公司规范运作》等要求，金浦钛业股份有限公司（以下简称"金浦钛 业"或"公司"）董事会，就公司在任独立董事单文峰、孙洋的独立 性情况进行评估并出具如下专项意见： ...

本人作为金浦钛业股份有限公司（以下简称"金浦钛业"或 "公司"）的独立董事，根据《公司法》《深圳证券交易所上市公 司自律监管指引第 1 号——主板上市公司规范运作》《上市公司独 立董事管理办法》等相关法律、行政法规、部门规章、规范性文件 及《公司章程》《独立董事制度》的规定和要求，在 2024 年的工作 中，忠实、勤勉、尽责地履行职务，及时了解公司的生产经营信息， 全面关注公司的发展状况，积极出席相关会议，认真审议董事会各 项议案，对公司相关事项发表独立意见，有效保证了公司运作的规 范性，切实维护了公司和股东尤其是社会公众股股东的合法利益。 现将本人 2024 年度履行职责情况汇报如下： 一、基本情况 金浦钛业股份有限公司 独立董事 2024 年度述职报告 （单文峰） 2、第八届董事会独立董事第四次专门会议"关于2024年度开展 外汇套期保值业务的议案""关于2024年度公司为下属合营公司提 供财务资助的议案"的独立意见。 本人单文峰，1971 年出生，法学硕士，高级律师，执业专利代 理师，现为北京大成（南京）律师事务所高级合伙人，兼任南京理 工大学知识产权学院校外研究生导师。2022 年 7 月起任本公司独 ...

Financial Performance - The company's operating revenue for Q1 2025 was ¥542,412,483.87, a decrease of 3.62% compared to ¥562,790,017.41 in the same period last year[5] - The net loss attributable to shareholders was ¥15,383,833.16, representing a 13.34% increase in loss from ¥13,572,719.27 year-on-year[5] - The net profit for the current period was CNY -15,393,150.97, compared to CNY -13,572,741.19 in the previous period, indicating an increase in net loss of about 13.4%[18] - The total comprehensive income for the current period was CNY -15,393,150.97, compared to CNY -13,572,741.19 in the previous period, indicating a worsening of about 13.4%[18] - The basic and diluted earnings per share for the current period were both CNY -0.0140, slightly worse than CNY -0.0138 in the previous period[18] Cash Flow - The net cash flow from operating activities improved by 43.11%, amounting to -¥16,876,393.93 compared to -¥29,664,710.51 in the previous year[5] - The cash flow from operating activities showed a net outflow of CNY -16,876,393.93, an improvement from CNY -29,664,710.51 in the previous period, reflecting a decrease in cash outflow of approximately 43.2%[20] - The company reported a total cash and cash equivalents balance of CNY 87,131,906.88 at the end of the period, down from CNY 133,083,760.14 in the previous period, a decline of about 34.5%[21] - The company generated CNY 230,434,978.64 in cash from sales of goods and services, a decrease of 18.5% from CNY 282,706,893.17 in the previous period[19] - The company’s investment activities resulted in a net cash outflow of CNY -52,177,663.86, an improvement from CNY -90,526,538.28 in the previous period, indicating a decrease in cash outflow of about 42.3%[20] Assets and Liabilities - Total assets increased by 1.79% to ¥3,008,376,072.36 from ¥2,955,573,106.43 at the end of the previous year[5] - Total current assets amounted to RMB 860,100,628.29, an increase of 7.5% from RMB 800,445,946.99[13] - Total liabilities increased to RMB 1,629,345,461.28, up from RMB 1,558,981,502.04, indicating a growth of 4.4%[14] - Total assets reached RMB 3,008,376,072.36, compared to RMB 2,955,573,106.43, marking an increase of 1.8%[14] - Non-current assets decreased slightly to RMB 2,148,275,444.07 from RMB 2,155,127,159.44, a decline of 0.3%[13] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 65,718, with no preferred shareholders[9] - The largest shareholder, Jinpu Investment Holdings, holds 25.81% of the shares, amounting to 254,700,000 shares, with a significant portion pledged[9] Research and Development - Research and development expenses decreased by 35.87% to ¥12,959,569.03 from ¥20,206,868.67 year-on-year[7] - The company incurred research and development expenses of CNY 12,959,569.03, down from CNY 20,206,868.67, representing a reduction of approximately 35.5%[17] Financing Activities - The company reported a significant increase in financing cash flow, which amounted to ¥26,749,427.25, a 2045.62% increase compared to -¥1,374,856.89 in the previous year[7] - The company raised CNY 312,000,000.00 through borrowings, an increase from CNY 252,000,000.00 in the previous period, reflecting a growth of approximately 23.8%[20] Operating Costs - The total operating costs for the current period were CNY 562,119,723.88, a decrease from CNY 580,547,962.53 in the previous period, representing a reduction of approximately 3.7%[17] - Accounts receivable rose by 36.16%, reaching ¥233,240,041.02, primarily due to an increase in receivables at the end of the reporting period[7] - Accounts receivable rose to RMB 233,240,041.02, up 36.2% from RMB 171,301,796.59 in the previous period[13] - Short-term borrowings increased to RMB 467,426,062.74 from RMB 442,284,207.95, reflecting a rise of 5.7%[14]

Corporate Governance - The company’s financial report is guaranteed to be true, accurate, and complete by the board of directors and senior management[3]. - The company emphasizes the importance of risk awareness regarding forward-looking statements in the annual report[3]. - The company has established a completely independent financial department and accounting system, ensuring no part-time personnel are involved[143]. - The company maintains an independent and complete organizational structure, with no subordinate relationships between the controlling shareholder and the company[142]. - The board of directors and supervisory board reports for the 2023 fiscal year were approved during the annual shareholders' meeting[144]. - The company has a governance structure that supports independent decision-making and financial operations[142][143]. - The company is focused on maintaining a high level of corporate governance and transparency in its operations[142]. - The company has established a remuneration management system for directors, supervisors, and senior management, approved on June 12, 2016[155]. - The remuneration system emphasizes principles such as equity between responsibilities and rights, alignment with company performance, and long-term sustainable development[155]. - The board approved a proposal for foreign exchange hedging activities for 2024, indicating a proactive approach to managing currency risk[157]. - The company has not reported any significant defects in non-financial reporting[181]. - The internal control evaluation report was also disclosed on April 29, 2025, and indexed on the Giant Tide Information Network[180]. Financial Performance - The company's operating revenue for 2024 was CNY 2,132,842,535.40, a decrease of 5.86% compared to CNY 2,265,584,334.90 in 2023[22]. - The net profit attributable to shareholders for 2024 was CNY 244,392,090.40, representing a decline of 39.81% from CNY 160,665,072.00 in 2023[22]. - The net cash flow from operating activities decreased by 89.94%, amounting to CNY 21,653,957.02 in 2024 compared to CNY 212,855,922.00 in 2023[22]. - The basic earnings per share for 2024 was -0.2477, a decrease of 39.86% from -0.1628 in 2023[22]. - Total assets at the end of 2024 were CNY 2,955,573,106.43, a decrease of 8.29% from CNY 2,926,917,813.00 at the end of 2023[22]. - The net assets attributable to shareholders decreased by 24.84% to CNY 1,146,649,604.67 in 2024 from CNY 1,369,440,760.00 in 2023[22]. - The company reported a significant decline in quarterly performance, with the fourth quarter net profit attributable to shareholders at -CNY 189,662,389.57[27]. - The company experienced a negative net profit for all four quarters of 2024, with the first quarter showing a loss of -CNY 13,572,719.27[27]. - The company has indicated uncertainty regarding its ability to continue as a going concern due to negative net profits in recent years[22]. - The company’s revenue and costs have shown a downward trend in 2024 due to weak market demand and price declines in titanium dioxide, leading to continuous losses over three years[52]. Business Transformation - The company has undergone a significant business transformation from pharmaceutical production to titanium dioxide production and sales since July 2013[19]. - The company’s main business focus is on the production and sales of titanium dioxide, a shift from its previous pharmaceutical focus[19]. - The company has undergone adjustments in its financial reporting due to business combinations under common control[21]. Market and Industry Trends - The titanium dioxide market demand is expected to continue growing with global economic recovery and accelerated infrastructure construction[41]. - The company aims to expand into emerging markets such as Southeast Asia, Africa, and South America to reduce reliance on single markets[37]. - The company is facing risks such as overcapacity, raw material price fluctuations, and international trade barriers, and is implementing strategies to mitigate these risks[113][115][117]. - The company anticipates intensified competition in the titanium dioxide industry due to increased domestic production capacity and export challenges, leading to a higher likelihood of market consolidation[134]. Research and Development - The company plans to enhance its research and development efforts, focusing on high-end product quality and performance to meet market demands[37]. - The company has established a technology center and has over a hundred patents to create technological barriers in the market[37]. - The company is developing high-gloss, high-dispersion titanium dioxide products to meet market demands, with the project completed in early 2023[79]. - The company is focusing on developing high-quality chemical fiber titanium dioxide to meet the growing demand in the synthetic fiber market, particularly targeting high-end nylon producers[82]. - The company is investing in research and development to tackle technical upgrade pressures and is collaborating with research institutions to overcome core technology challenges[120]. Environmental and Social Responsibility - The company is committed to building a green manufacturing system and establishing a safety production responsibility management mechanism[105]. - The company has achieved compliance with various pollutant discharge standards, including COD, ammonia nitrogen, and total phosphorus, with specific discharge amounts meeting regulatory limits[184]. - The company has made continuous investments in environmental management, enhancing its capabilities in environmental protection[187]. - The company actively participates in social responsibility initiatives, including volunteer services and support for disadvantaged groups, with a blood donation amount reaching 36,200 milliliters in 2024[195]. Strategic Initiatives - The company is focusing on circular economy practices, effectively utilizing waste resources and reducing production costs through various recycling initiatives[48]. - The company is extending its industrial chain into the new energy sector, leveraging titanium dioxide by-products and establishing strategic partnerships with leading new energy firms[112]. - The company is currently experiencing a slowdown in the construction of phosphate iron facilities due to market conditions, while sulfuric acid facilities are progressing as planned[127]. - The company is actively seeking low-cost bank loans to finance its projects following the withdrawal of a share issuance plan[124]. Personnel and Management Changes - The company is focusing on strategic personnel changes to enhance management efficiency and operational effectiveness[147]. - The company is actively pursuing talent acquisition and management restructuring to align with its growth strategy[152]. - The company has experienced multiple executive resignations, including the CFO Xing Yi on November 26, 2024, and Vice General Manager Wu Yue on November 28, 2024, both due to personal reasons[148]. Financial Management - The company has established a comprehensive internal control system focusing on internal environment, risk assessment, control activities, information communication, and internal supervision[173]. - The company has identified internal risks related to production safety, employee health, environmental protection, financial status, and compliance management[175]. - The company has implemented control measures based on risk assessment results, including separation of incompatible duties and budget control[177].

金浦钛业（000545）公告，2025年第一季度营业收入5.42亿元，同比下降3.62%。净亏损1538.38万元， 去年同期净亏损1357.27万元。 ...

证券代码：000545 证券简称：金浦钛业 公告编号：2025-037 金浦钛业股份有限公司 关于出售下属子公司股权的进展公告 本公司及董事会全体成员保证公告内容真实、准确和完整，无任 何虚假记载、误导性陈述或者重大遗漏。 一、交易概述 金浦钛业股份有限公司（以下简称"金浦钛业"或"公司"）分 别于 2025 年 2 月 28 日、2025 年 3 月 19 日召开第八届董事会第三十 七次会议和 2025 年第二次临时股东大会，审议通过了《关于出售下 属子公司股权的议案》，同意公司全资子公司南京钛白化工有限责任 公司（以下简称"南京钛白"）出售其持有的上海东邑酒店管理有限 公司（以下简称"东邑酒店公司"）100%股权，交易对手方为马鞍山 市文天教育发展有限公司、江苏大业投资有限公司、无锡市大业房屋 建设开发有限公司。具体内容详见公司于 2025 年 3 月 3 日发布的《关 于出售下属子公司股权的公告》（公告编号：2025-017）。 二、交易进展情况 截至本公告披露日，公司已收到交易款项合计 178,676,003.33 元，东邑酒店公司已完成本次股权出售的工商变更登记手续。变更完 成后，南京钛白不再持有东 ...

038 证券代码：000545 股票简称：金浦钛业 公告编号：2025- 金浦钛业股份有限公司 控股股东所持公司部分股份将被第二次司法拍卖的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有 任何虚假记载、误导性陈述或者重大遗漏。 特别提示： 1、本次司法拍卖标的为金浦钛业股份有限公司（以下简称"金 浦钛业"或"公司"）控股股东金浦投资控股集团有限公司（以下简 称"金浦集团"）持有的公司 34,000,000 股股份，为无限售流通股， 占其所持公司全部股份的 13.35%，占公司总股本的 3.45%。 2、如本次司法拍卖最终成交，金浦集团将被动减持本公司股份， 减持后金浦集团持有公司股份 220,700,000 股，占公司总股本的 22.36%，仍为公司控股股东，本次司法拍卖不会导致公司控制权发生 变更。 3、金浦集团持有的公司股份中被司法冻结及司法标记的股份比 例达到 100%，请投资者注意相关风险。 一、股东股份将被第二次司法拍卖的基本情况 | | 是否为控股 | | | | 是否 为限 | | | | | --- | --- | --- | --- | --- | --- | --- | - ...

电池产业的"吸金"能力依旧，但随着新一轮竞争周期的到来，此时的扩产投资风向已经发生了较大的变化。 据起点锂电观察，自2020年开始的锂电产业扩产潮，从无序化正逐步转化为按需投资，随着竞争格局清晰，各领域的布局也更为谨慎。 从项目上来看，各赛道均有项目"喊停"，而这背后的原因与转变都有明显的特点。 01 多个锂电项目折戟 不完全统计，2025年以来已有多个锂电项目被撤回，其中4月份"撤单"数量明显增多。 电池端， 欣旺达4月22日发布公告叫停两大项目 ，分别为 欣旺达30GWh动力电池生产基地项目、 欣智旺智能硬件宁乡综合生产基地项目， 其中就包括百亿级别 动力电池生产项目。 据了解，欣旺达 原计划投资 120亿元，在 珠海市建设30GWh动力电池生产基地， 从事动力电芯、电池模组和电池系统的研发、设计、 生 产及销售。 材料端， 芳源股份4月17日公告宣布终止投资 电池级碳酸锂生产及废旧磷酸铁锂电池综合利用项目。 项目原计划 总投资金额不超过30亿元，分两期建设年产3万吨电池级碳酸锂及4.6万吨磷酸铁前驱体项目（一期）、年产4万吨磷酸铁锂正极 材料项目（二期）。 金浦钛业4月7日公告表示，将终止投资合资公 司 ...

出品：新浪财经上市公司研究院 作者：昊 专题：新浪财经上市公司研究院 日前，金浦钛业发布公告称，综合考虑全资子公司南京钛白的资金现状，以及磷酸铁项目暂缓的状态，决定终止与兰州金川科技园有限公司、甘肃镍都产业 投资基金有限合伙共同投资设立参股公司甘肃金麟锂电新材料有限公司（以下称"甘肃金麟"）的投资计划。 这也意味着，公司彻底退出20万吨/年的磷酸铁项目，转型锂电三年再次遭遇重大挫折。 金浦钛业原主业为钛白粉，因副产品硫酸亚铁可直接用于制备磷酸铁，借此转型新能源赛道。2022年4月，公司设立金浦新能源，并规划建设20万吨/年磷酸 铁和20万吨/年磷酸铁锂项目，总投资近100亿，而当时公司账面现金仅4.5亿。 此后三年，金浦钛业营收持续下滑并连续亏损，直到此次终止投资，参股公司注册资金仍实缴为0。 连年亏损叠加近三次定增融资全部失败，金浦钛业资金面极为紧张，负债率屡创新高，在现金无法覆盖短债的情况下，仍计划接盘两家基金持有的金浦新能 源剩余49%股份。而为了回笼资金，金浦钛业被迫以0.5亿对价，变卖5年前2.4亿收购的东邑酒店。 值得注意的是，公司控股股东金浦集团已质押87%的股份，其股权司法拍卖也出现流拍，金浦 ...

Group 1: Battery Industry Developments - CATL plans to advance its listing in Hong Kong this quarter despite expected market volatility due to trade tensions, with details such as fundraising amounts still to be finalized [2] - Nandu Power recently showcased its 30Ah all-solid-state battery, which features a high nickel ternary positive electrode and silicon-carbon negative electrode, achieving an energy density of 350Wh/kg and maintaining over 92% capacity after 500 charge-discharge cycles [3] - The first batch of energy efficiency grading results for pure electric passenger vehicles was released, covering 12 mainstream models, with 8 domestic and 3 joint venture models receiving "一级能效" ratings [4] Group 2: Material and Investment Adjustments - Rongbai Technology announced a reduction in its planned annual production capacity for its lithium battery materials project from 60,000 tons to 30,000 tons, with the first phase already completed [4] - Jinpu Titanium Industry announced the termination of its investment in a 200,000-ton lithium iron phosphate project due to the current financial status of its subsidiary and the project's postponement [6] Group 3: International Developments - ICL announced the opening of the first lithium iron phosphate battery material pilot production base in the U.S., located in St. Louis, Missouri, with an investment of $20 million and a pilot manufacturing capacity of 1-ton level [9]